Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 12/20 | 0.40 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21392008 | 0.95 | CYP2C19 (0.44) | CYP2C19SIGMAR1RAPGEF4 | |
| SCHEMBL13136832 | 0.95 | CYP2C19 (0.44) | CYP2C19SIGMAR1RAPGEF4 | |
| SCHEMBL17678530 | 0.93 | BCL2 (0.46) | BCL2SIGMAR1PTGS2NISCH | |
| SCHEMBL1858399 | 0.92 | BCL2 (0.41) | BCL2CYP2C19SIGMAR1RAPGEF4PTGS2 | |
| SCHEMBL12798297 | 0.91 | CYP2C19 (0.50) | CYP2C19SIGMAR1RAPGEF4KDM4EALDH1A1 | |
| SCHEMBL14114271 | 0.89 | BCL2 (0.44) | BCL2SIGMAR1PTGS2NISCH | |
| SCHEMBL1702238 | 0.89 | SIGMAR1 (0.48) | BCL2CYP2C19SIGMAR1PTGS2KDM4E | |
| SCHEMBL4576079 | 0.89 | SIGMAR1 (0.48) | BCL2CYP2C19SIGMAR1PTGS2KDM4E | |
| SCHEMBL10301479 | 0.89 | SIGMAR1 (0.43) | BCL2CYP2C19SIGMAR1PTGS2ALDH1A1 | |
| SCHEMBL12533849 | 0.88 | BCL2 (0.50) | BCL2CYP2C19SIGMAR1PTGS2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11067909-B2 | Terphenyl compound, electrophotographic photosensitive member, and method for producing terphenyl compound | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2021-07-20 | — | — | US | disclosed |
| US-11003101-B2 | Electrophotographic photosensitive member, process cartridge, and image forming apparatus | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2021-05-11 | — | — | US | disclosed |
| US-10996575-B2 | Electrophotographic photosensitive member, process cartridge, and image forming apparatus | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2021-05-04 | — | — | US | disclosed |
| US-20200233324-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2020-07-23 | — | — | US | disclosed |
| US-20200233323-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2020-07-23 | — | — | US | disclosed |
| US-20200231535-A1 | TERPHENYL COMPOUND, ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, AND METHOD FOR PRODUCING TERPHENYL COMPOUND | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11067909-B2 | Terphenyl compound, electrophotographic photosensitive member, and method for producing terphenyl compound | ABCB1, TERB1, PAH | BCL2 3941/4885CYP2C19 101/4885SIGMAR1 3418/4885 |
| US-20200231535-A1 | TERPHENYL COMPOUND, ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, AND METHOD FOR PRODUCING TERPHENYL COMPOUND | ABCB1, TERB1, PAH | BCL2 3941/4885CYP2C19 101/4885SIGMAR1 3418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.